<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-19T12:38:16Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/12737" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/12737</identifier><datestamp>2025-10-24T10:27:07Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Brentuximab vedotin compared with historical controls for severe skin involvement in cutaneous systemic sclerosis</dc:title>
   <dc:creator>Fernández Codina, Andreu</dc:creator>
   <dc:creator>Nevskaya, Tatiana</dc:creator>
   <dc:creator>Baron, Murray</dc:creator>
   <dc:creator>Appleton, Christopher Thomas</dc:creator>
   <dc:creator>Cecchini, Matthew</dc:creator>
   <dc:creator>Philip, Amanda</dc:creator>
   <dc:subject>Anticossos monoclonals - Ús terapèutic</dc:subject>
   <dc:subject>Avaluació de resultats (Assistència sanitària)</dc:subject>
   <dc:subject>Esclerodèrmia - Tractament</dc:subject>
   <dc:subject>Medicaments immunosupressors - Tractament</dc:subject>
   <dc:subject>DISEASES::Skin and Connective Tissue Diseases::Connective Tissue Diseases::Scleroderma, Systemic</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::Other subheadings::/drug therapy</dc:subject>
   <dc:subject>CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Immunologic Factors::Immunosuppressive Agents</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::/therapeutic use</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome</dc:subject>
   <dc:subject>ENFERMEDADES::enfermedades de la piel y tejido conjuntivo::enfermedades del tejido conjuntivo::esclerodermia sistémica</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia</dc:subject>
   <dc:subject>COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::factores inmunitarios::inmunosupresores</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::/uso terapéutico</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento</dc:subject>
   <dcterms:abstract>Severe skin involvement; Cutaneous systemic sclerosis</dcterms:abstract>
   <dcterms:abstract>Afectació cutània; Esclerosi sistèmica cutània</dcterms:abstract>
   <dcterms:abstract>Afectación cutánea; Esclerosis sistémica cutánea</dcterms:abstract>
   <dcterms:abstract>Investigator-initiated study. Seagen provided partial funding and interpretation of the data. Seagen had courtesy access to the final manuscript, without having influence on the final publication.</dcterms:abstract>
   <dcterms:dateAccepted>2025-10-24T10:27:07Z</dcterms:dateAccepted>
   <dcterms:available>2025-10-24T10:27:07Z</dcterms:available>
   <dcterms:created>2025-10-24T10:27:07Z</dcterms:created>
   <dcterms:issued>2025-03-11T08:58:34Z</dcterms:issued>
   <dcterms:issued>2025-03-11T08:58:34Z</dcterms:issued>
   <dcterms:issued>2025-02</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>http://hdl.handle.net/11351/12737</dc:identifier>
   <dc:relation>Rheumatology;64(2)</dc:relation>
   <dc:relation>https://doi.org/10.1093/rheumatology/keae460</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>Oxford University Press</dc:publisher>
   <dc:source>Scientia</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>